Payer PolicyActive
CG-SURG-25 Injection Treatment for Mortonâs Neuroma
ANTHEM-CG-SURG-25
Anthem
Effective: July 1, 2025
Updated: December 30, 2025
Policy Summary
This policy addresses injection treatment for Morton’s neuroma using anesthetic, sclerosing (neurolytic), or steroid agents. Coverage is medically necessary only after failure of all conservative measures: padding/orthotics, activity modification, shoe-wear changes (e.g., wider toe box), and medications unless contraindicated; injections are not medically necessary if these criteria are not met.
Coverage Criteria Preview
Key requirements from the full policy
"Injections of anesthetic, sclerosing (neurolytic), or steroid agents are consideredmedically necessaryfor treatment of Mortonâs neuroma whenallof the following conservative therapies have failed:"
Sign up to see full coverage criteria, indications, and limitations.